Primary leiomyosarcoma of the inferior vena cava (IVC) is a rare malignant tumor. Herein, we report the case of a 52-year-old male patient who had postprandial abdominal distension and right upper quadrant abdominal pain. The abdominal computed tomography (CT) angiogram showed an IVC mass extending from the infrahepatic to the suprarenal inferior vena cava. The radiologic findings were suggestive of an IVC leiomyosarcoma. Surgical resection and reconstruction with a cryopreserved homograft were performed. The follow-up abdominal CT angiogram revealed the patient to be disease-free 6 months after surgery with patency of the IVC and renal vein. 
In an operation via inverted L-shaped incision laparotomy, the right hepatic lobe was dissected for IVC mobilization and was rotated and elevated to the left side. Retrohepatic IVC was fully dissected to secure sufficient space for a proximal clamp and venous cannulation. To prevent venous hypertension during tumor removal and vascular reconstruction, a veno-venous bypass was performed via the left femoral vein to the proximal retrohepatic IVC by using a centrifugal biopump (Medtronic Biomedicus Inc., Minneapolis, MN, USA).
After the proximal and distal clamp, the tumor and the involved IVC were completely removed from the infrahepatic IVC to just above the right renal vein. The left renal vein ostium was also resected because of tumor involvement. A frozen section showed that all resection margins were cleared.
The tumor characteristics were as follows: a hard yellowish lobulating mass with extraluminal extension (Fig. 2B ).
However, tumor invasion into the perivascular tissue was not 
DISCUSSION
Primary leiomyosarcoma of the IVC is a rare malignant tumor (2% of all leiomyosarcomas) but can be a fatal disease [1] . The 5-and 10-year malignancy-free survival rates after a wide surgical resection by using the Mingoli register were 31.4% and 7.4%, respectively [2] . The clinical diagnosis is usually delayed because the malignancy is often asympto- Survival of the patients with IVC leiomyosarcoma depends on curative tumor resection, its anatomic site, histological grade, invasion of the adjacent structures, and histologic subtype [3] . It has been observed that en bloc surgical resection with negative margins of more than 1 cm is the only treatment that improves survival [3, 5] . However, surgical procedures can be complex due to the tumor involvement in the renal vein confluence and at the retrohepatic location.
Therefore, nephrectomy, kidney auto-transplantation, or re-attachment of the tumor-free renal vein stump to the re- been established yet because of the insufficient respondence [1, 5] . Therefore, there have been several previous reports that the adjuvant chemo-radiotherapy might not have any benefits in patients with complete tumor resection [2, 4, 6] . We consulted a chemo-oncologist and a radiation oncologist about the adjuvant therapy after discharge, but they did not recommend either chemotherapy or radiotherapy to our patient because of the lack of evidence and the toxicity to other major organs.
Usually, when the IVC needs to be replaced, reinforced polytetrafluoroethylene (PTFE) prosthetic grafts of various sizes have been commonly used [4, 7] . However, the limits of this well-established graft are mainly the risk of prosthetic graft occlusion and/or infection [7] . Therefore, creation of an arteriovenous fistula and long-term anticoagulation therapy are often recommended to ensure graft patency [4, 7] .
A banked venous homograft can be an alternative option. It has been used for limb salvage surgery or peripheral vein resection in sarcomas of the extremities as a bypass graft and for neo-aortic reconstruction [7] . However, few reports on the restoration of caval continuity have been published; specifically, only two previous cases have been reported in which a banked venous homograft was used for the reconstruction of a resected IVC [3, 7] . Vena caval replacement with a homograft has several advantages when compared to replacement with PTFE grafts. Cross-sectional luminal narrowing in PTFE grafts, ranging from 16% to 40%, has been reported during follow-up. However, the venous homograft showed a relatively mild degree of graft stenosis and lower rates of luminal narrowing, ranging from 2% to 9%. These findings may be associated with the lack of immune response to the venous homograft. Several studies have shown that the homograft has virtually no cellular or humoral immune responses because the homograft was repopulated by endothelial lining of the recipient, and a subendothelial region recellularized by myofibroblasts [3] . Furthermore, the slow progression of luminal obstruction by the adaptive remodeling process in the homograft may provide more time for the collateral vessels to develop [7, 8] . Therefore, the need for anticoagulation therapy after surgery might be mitigated. Graft availability is the only limiting factor of the use of a homograft.
In our case, we planned the reconstruction of the IVC with In this report, the feasibility and safety of the cryopreserved vena caval homograft replacement is documented.
Therefore, it can be considered a good alternative graft to the reconstruction of IVC in the case of a rare primary leiomyosarcoma.
